Rhythm Pharmaceuticals

Kiniksk Pharmaceuticals Corp is a biopharmaceutical company based in Wellesley Hills, MA, specializing in the research and development of innovative medical treatments. With a focus on cutting-edge technology and scientific advancements, Kiniksk Pharmaceuticals Corp aims to improve patient outcomes and contribute to the advancement of healthcare globally. Generated from their business information

Alnylam Pharmaceuticals is a biopharmaceutical company. The company develops novel therapeutics based on the biological breakthrough known as ribonucleic acid interference. The company applies ribonucleic acid interference to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies. This discovery enables the creation of a broad new class of human therapeutics. Alnylam Pharmaceuticals maintains partnerships with leading pharmaceutical and medical technology companies to drive further developments and capabilities. Major alliances include Merck, Medtronic and Novartis. Alnylam Pharmaceuticals, founded in 2002, maintains global headquarters in Cambridge, Mass., and has an additional operating unit in Kulmbach, Germany.

Rubius Therapeutics is a clinical-stage biotechnology company based in Cambridge, MA, specializing in the development of programmable epigenomic mRNA medicines for precise control of gene regulation and cellular function. Through their OMEGA platform, they utilize computational genomics, machine learning, and artificial intelligence to design innovative therapeutics that target a wide range of diseases. With a focus on patient needs, Rubius Therapeutics is driven by a world-class team of ambitious and resilient leaders, thinkers, and scientists. Their pipeline consists of diverse biology, tissue, and disease types, aiming to address previously challenging medical conditions and transform the field of precision medicine.Generated from the website